{"id":"W2889338440","doi":"10.1111/bjd.17084","title":"Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma; Mylan; Astellas Pharma; University of Connecticut; Valeant Pharmaceuticals International; National Cancer Institute; AbbVie; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Adalimumab; Medicine; Psoriasis; Plaque psoriasis; Dermatology; Clinical trial; Term (time); Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121729,0.0002539469,0.002011008,0.0002318751,0.0001132935,0.00001950881,0.0003474357,0.0005279768,0.0005007687],"category_scores_gemma":[0.0006583265,0.0002288529,0.0003178946,0.0001835917,0.0003487072,0.0001611636,0.00007831591,0.0004004935,0.00007273287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004713358,"about_ca_system_score_gemma":0.0002250867,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002353367,"about_ca_topic_score_gemma":0.0007917105,"domain_scores_codex":[0.9939992,0.002795072,0.00239091,0.0003251402,0.0001000583,0.0003896019],"domain_scores_gemma":[0.9958951,0.00152999,0.001311288,0.0002296272,0.0009426219,0.00009134991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03450096,0.001551526,0.8188318,0.00003551271,0.002617219,0.001387897,0.0005692822,0.000009081074,0.0007704493,0.00003417983,0.007195152,0.132497],"study_design_scores_gemma":[0.03925722,0.001227525,0.9429474,0.0006875003,0.0004660178,0.005821445,0.0001443805,0.000001758986,0.008024622,0.0001086597,0.0009936508,0.0003198277],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950658,0.001796013,0.0004050971,0.0002184961,0.00155056,0.0003835117,0.0004568456,0.00001184576,0.0001117925],"genre_scores_gemma":[0.9977992,0.0008833796,0.0006551077,0.000301971,0.0001457016,0.000008159992,0.0001525234,0.00002498111,0.00002904672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1321771,"threshold_uncertainty_score":0.9332349,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04027400225608697,"score_gpt":0.3101895344118434,"score_spread":0.2699155321557565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}